A review of new science, in plain language

Proceedings of the National Academy of Sciences  ·  31 July 2026  ·  From issue 15

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies

Blocking antibodies in myasthenia gravis patients raised the risk of severe COVID pneumonia up to 12 times.

Adrian Gervais, Astrid Marchal et al.

Integrity screen: passed (3 checks) Checked 3 August 2026. Read the source

The plain-language reading of this paper is in the full issue, for subscribers.

Read the full issue

Get it free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 15 15 papers
More from Proceedings of the National Academy of Sciences